MicroRNA-574-5p Was Pivotal for TLR9 Signaling Enhanced Tumor Progression via Down-Regulating Checkpoint Suppressor 1 in Human Lung Cancer

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Li, Qinchuan ^a   Li, Xiaoman ^b   Guo, Zhongliang ^a   Xu, Feng ^c   Xia, Jingyan ^c   Liu, Zhongmin ^a   Ren, Tao ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT SUPPRESSOR 1 PROTEIN; MICRORNA; MICRORNA 574 5P; TOLL LIKE RECEPTOR 9; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL CYCLE PROGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MALE; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR VOLUME; UPREGULATION;

AGED; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; CPG ISLANDS; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; MIDDLE AGED; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 84868323256     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048278     Document Type: Article

References (30)

1. Janeway CA Jr, Medzhitov R, (2002) Innate immune recognition. Annu Rev Immunol 20: 197-216.
2. Takeda K, Kaisho T, Akira S, (2003) Toll-like receptors. Annu Rev Immunol 21: 335-376.
3. Ren T, Xu L, Jiao S, Wang Y, Cai Y, et al. (2009) TLR9 signaling promotes tumor progression of human lung cancer cell in vivo. Pathol Oncol Res 15: 623-630.
4. Xu L, Wang C, Wen Z, Yao X, Liu Z, et al. (2010) Selective up-regulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell. Immunol Lett 127: 93-99.
5. Huang B, Zhao J, Li H, He KL, Chen Y, et al. (2005) Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65: 5009-5014.
6. He W, Liu Q, Wang L, Chen W, Li N, et al. (2007) TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44: 2850-2859.
7. Huang B, Zhao J, Unkeless JC, Feng ZH, Xiong H, (2008) TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27: 218-224.
8. Chen R, Alvero AB, Silasi DA, Steffensen KD, Mor G, (2008) Cancers take their Toll-the function and regulation of Toll-like receptors in cancer cells. Oncogene 27: 225-233.
9. Ren T, Wen ZK, Liu ZM, Liang YJ, Guo ZL, et al. (2007) Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis. Cancer Biol Ther 6: 1704-1709.
10. Xu L, Zhou Y, Liu Q, Luo JM, Qing M, et al. (2009) CXCR4/SDF-1 pathway is crucial for TLR9 agonist enhanced metastasis of human lung cancer cell. Biochem Biophys Res Commun 382: 571-576.
11. Wang C, Fei G, Liu Z, Li Q, Xu Z, et al. (2012) HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells. Cancer Biol Ther; in press.
12. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
13. Ambros V, (2003) MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113: 673-676.
14. Gao W, Xu J, Shu YQ, (2011) miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer. Expert Rev Respir Med 5: 699-709.
15. Garzon R, Calin GA, Croce CM, (2009) MicroRNAs in Cancer. Annu Rev Med 60: 167-179.
16. Bai Y, Qian C, Qian L, Ma F, Hou J, et al. (2012) Integrin CD11b Negatively Regulates TLR9-Triggered Dendritic Cell Cross-Priming by Upregulating microRNA-146a. J Immunol 188: 5293-5302.
17. Sun Y, Cai J, Ma F, Lü P, Huang H, et al. (2012) miR-155 mediates suppressive effect of progesterone on TLR3, TLR4-triggered immune response. Immunol Lett; in press.
18. Alam MM, O'Neill LA, (2011) MicroRNAs and the resolution phase of inflammation in macrophages. Eur J Immunol 41: 2482-2485.
19. Ren T, He X, Cai Y, Wang Y, (2011) TLR9 agonist enhances lung cancer invasiveness by alternating miRNA expression profile. Sci Res Essays 6: 2519-2524.
20. Huang Z, Huang S, Wang Q, Liang L, Ni S, et al. (2011) MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. Cancer Res 71: 2582-2589.
21. Ebert MS, Neilson JR, Sharp PA, (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4: 721-726.
22. Huang J, Zhao L, Xing L, Chen D, (2010) MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 28: 357-364.
23. Du C, Liu C, Kang J, Zhao G, Ye Z, et al. (2009) MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 10: 1252-1259.
24. Chen YJ, Liao CT, Chen PJ, Lee LY, Li YC, et al. (2011) Downregulation of Ches1 and other novel genes in oral cancer cells chronically exposed to areca nut extract. Head Neck 33: 257-266.
25. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, et al. (2011) miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 6: 482-488.
26. Pati D, Keller C, Groudine M, Plon SE, (1997) Reconstitution of a MEC1-independent checkpoint in yeast by expression of a novel human fork head cDNA. Mol Cell Biol 17: 3037-3046.
27. Busygina V, Kottemann MC, Scott KL, Plon SE, Bale AE, (2006) Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response. Cancer Res 66: 8397-8403.
28. Chang JT, Wang HM, Chang KW, Chen WH, Wen MC, et al. (2005) Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1. Int J Cancer 114: 942-949.
29. Markowski J, Tyszkiewicz T, Jarzab M, Oczko-Wojciechowska M, Gierek T, et al. (2009) Metal-proteinase ADAM12, kinesin 14 and checkpoint suppressor 1 as new molecular markers of laryngeal carcinoma. Eur Arch Otorhinolaryngol 266: 1501-1507.
30. Markowski J, Oczko-Wojciechowska M, Gierek T, Jarzab M, Paluch J, et al. (2009) Gene expression profile analysis in laryngeal cancer by high-density oligonucleotide microarrays. J Physiol Pharmacol 60: 57-63.